title: Somatostatin or its analogs and terlipressin: Different evidence levels, Same recommendations?
authors.forename: Yu
authors.initials: Y
authors.lastname: Bai
authors.forename: Jun
authors.initials: J
authors.lastname: Gao
authors.forename: Duo-Wu
authors.initials: DW
authors.lastname: Zou
authors.forename: Zhao-Shen
authors.initials: ZS
authors.lastname: Li
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004932:Esophageal and Gastric Varices / Q000517:prevention & control*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000077585:Terlipressin
chemical_list: D000959:Antihypertensive Agents; D006728:Hormones; D008236:Lypressin; D013004:Somatostatin; D000077585:Terlipressin